Monday, 28 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Drug
Zelgen Biopharma’s ZG005 Approved for Gastrointestinal Tumor Trials in China
April 10, 2025
Company
Drug
HemaCell’s XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome
April 10, 2025
Company
Drug
IVIEW Therapeutics’ IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis
April 10, 2025
Company
Drug
Hansoh Pharma’s Ibrexafungerp Approved for Vulvovaginal Candidiasis in China
April 10, 2025
Company
Drug
Hengrui Pharmaceuticals’ Ivarmacitinib Approved for Atopic Dermatitis
April 10, 2025
Company
Drug
Beijing StarMab’s SM2275 Receives FDA IND Approval for Dual-Target Cancer Therapy
April 10, 2025
Company
GE Healthcare Appoints Jeannette Bankes as President and CEO of Patient Care Solutions
April 10, 2025
Company
Medical Device
Wantai Bio’s Tuberculosis Test Kit Joins UNOPS StopTB Procurement List
April 10, 2025
Company
Drug
B. Braun’s DUPLEX System Approved by FDA for Piperacillin and Tazobactam
April 10, 2025
Company
Drug
Sino Biopharma’s TQB3019 Gains NMPA Approval for Hematological Malignancies
April 10, 2025
Company
Medical Device
Peijia Medical’s YonFlow Stent Approved by China’s NMPA
April 10, 2025
Company
Medical Device
Gaush Meditech’s Corneal Confocal Microscope Approved in Jiangsu
April 10, 2025
1
2
…
397
398
399
400
401
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?